"If Tunisia wants to be a leading country in terms of exports in the pharmaceutical sector it needs to continue along the lines of what is…
In Conversation
"Policymakers need to look at the industry’s issues today, and provide the clear guidance on how the government could help resolve them."
“Working in technology had quickly made me realize that my scientific vocation could find challenging objectives in industry too.”
"We took the bold decision in 2012 to enter into the OTC and dietary supplements market. These areas are less regulated, and allow us to split…
"We believe that if we can create multiple patient-centric healthcare eco-systems in developing nations like India - that’s true leadership, because only then can we truly…
"Poland has the bright minds on hand to kick start larger investments, but it also needs institutional support and must tackle legislative areas head-on to simplify…
"Unlike some of our competitors, we operate on a global formulations strategy, meaning that we can leverage our global manufacturing capacity to meet the needs of…
"Companies allocate a certain proportion of funds to support our operations, such as conferences and events, though perhaps we must do more to convince them to…
"Thanks to our longstanding strategy of diversification, we are able to cater to the geopolitical conditions in Africa, while investigating potential areas of development outside the…
"The Minister of economic development and finance, Mateusz Morawiecki, is equally attempting to find a solution to simplify the system, although, the efforts of the government…
"A company like ours that is driven by innovation understands that there needs to be space for innovation."
"AstraZeneca Bulgaria is having unique standing on the marketplace today, with a strong self-esteem and confidence in our science and our products."
